Dr. Seemal Desai is a Diplomate of the American Board of Dermatology, and a Board Certified Dermatologist. He graduated with honors from Emory University. He received his medical training at Morehouse School of Medicine in Atlanta, Georgia, and received his Doctor of Medicine degree with Magna Cum Laude with honors.
Following medical school, Dr. Desai completed his medical internship in Internal Medicine. He then went on to complete his residency at The University of Alabama at Birmingham and served as Chief Resident for the Department of Dermatology.
Dr. Desai has been active on a local, state, and national level with numerous medical organizations, and is also actively involved in teaching and mentoring medical students and residents. He is the Founder & Medical Director of Innovative Dermatology, a state-of-the-art private practice in the Dallas area, and also serves as Clinical Assistant Professor of Dermatology at The University of Texas Southwestern Medical Center.
Dr. Desai is the author of numerous publications and has been invited to present at countless national and international Dermatology events. His clinical expertise includes the treatment of vitiligo, and other disorders of pigmentation, psoriasis, acne, skin disease in skin of color, cosmeceuticals, and new drug therapies. Dr. Desai is very active in the dermatologic community and is the Past President of the Skin of Color Society, and Past President of the Texas Dermatological Society. In addition, he is a Past President of the Dallas/Ft. Worth Dermatological Society. He also serves on the Board of Directors of the International Society of Dermatology, the Board of Directors of the Women’s Dermatologic Society, the Board of Directors of the Global Vitiligo Foundation, and has been on the Board of SkinPAC and the Skin of Color Society. In 2017, Dr. Desai was elected to the American Academy of Dermatology Board of Directors, and also served on the AAD Executive Committee. Most recently, Dr. Desai was elected as the next President-Elect of the American Academy of Dermatology, and is the youngest dermatologist to ever be elected AAD President. He will begin his term as AAD President-Elect in 2023, and as AAD President in 2024. In 2017, and again in 2021, Dr. Desai was appointed to serve on the US Food & Drug Administration, Pharmacy Compounding Advisory Committee (PCAC), and is the only dermatologist on this federal hearing committee. He has just been reappointed to another full 4 year term. He also serves as the Associate Editor of the Journal of Clinical & Aesthetic Dermatology and Pigment International. He has given over 150+ lectures nationally and internationally, and is passionate about advocacy and advancement of our specialty. He is married and has one daughter and one son.